SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

SVB Leerink Maintains Market Perform on Intersect ENT, Raises Price Target to $15

SVB Leerink maintains Intersect ENT (NASDAQ:XENT) with a Market Perform and raises the price target from $13 to $15.

Benzinga · 05/12/2020 17:00

SVB Leerink maintains Intersect ENT (NASDAQ:XENT) with a Market Perform and raises the price target from $13 to $15.